Clinicopathological characteristics of uninvestigated dyspepsia in Spain;Características clinicopatológicas de la dispepsia no investigada en España

Gastroenterologia y Hepatologia

Volumn 30, Issue 1, 2007, Pages 1-6

  Pérez Grueso Macías, María José ^a   Valle Muñoz, Julio ^a   Gonzãlez De Frutos, Concepciõn ^a   Artaza Varasa, Tomás ^a   Rodríguez Merlo, Rufo ^a   Alcántara Torres, Mariano ^a   Carrobles Jiménez, José María ^a  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATROPHIC GASTRITIS; BIOPSY; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPEPSIA; FEMALE; GASTROSCOPY; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; SPAIN; UREA BREATH TEST;

EID: 33846910059     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13097442     Document Type: Article

References (33)

1. Talley NJ. Dyspepsia. Gastroenterology. 2003;125:1219-26.
2. Talley NJ, Silverstein MD, Agréus L, Nyren O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. Gastroenterology. 1998;114:582-95.
3. Talley NJ, Vakil NB, Moayyedi P. AGA technical review on the evaluation of dyspepsia. Gastroenterology. 2005;129:1756-80.
4. Veldhuyzen van Zanten SJ, Flook N, Chiba N, Armstrong D, Barkun A, Bradette M, et al. An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMAJ. 2000;162Suppl 12:3-23.
5. Barenys M, Abad A, Pons JM, Moreno V, Rota R, Granados A, et al. Scoring system has better discriminative value than Helicobacter pylori testing in patients with dyspepsia in a selling with high prevalence of infection. Eur J Gastroenterol Hepatol. 2000;12:1275-82.
6. Talley J, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders. Gut. 1999;45 Suppl 2:37-42.
7. Soll AH. Consensus conference. Medical treatment of peptic ulcer disease: practice guidelines. Practice Parameters of the American College of Gastroenterology. JAMA. 1996;275:622-9.
8. Lambert JR. The role of Helicobacter pylori in nonulcer dyspepsia. A debate-for. Gastroenterol Clin North Am. 1993;22:141-51.
9. Laheij RJF, Van Rossum LGM, Verbeek ALM, Jansen JBMJ. Helicobacter pylori infection treatment of nonulcer dyspepsia. An analysis of meta-analyses. J Clin Gastroenterol. 2003;36:315-20.
10. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al. Erradicación de Helicobacter pylori para la dispepsia no ulcerosa (revisión Cochrane traducida). En: Biblioteca Cochrane Plus 2005 no. 2. Oxford: Update Software Ltd.: 2002.
11. Talley NJ, Vakil N. Guidelines for the management of dispepsia. Am J Gastroenterol. 2005;100:2324-37.
12. Calvet X. Helicobacter pylori eradication treatment in non-ulcerous disease. Gastroenterol Hepatol. 2005; 28:40-46.
13. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175-86.
14. Cassaro M, Rugge M, Gutiérrez O, Lendro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000;95:1431-6.
15. Rubin CE. Are there three types of Helicobacter pylori gastritis? Gastroenterology. 1997;112:2108-10.
16. Sainz S, Mirelis B, González D, Sancho FJ, Monés J. Diagnóstico de la infección por Campylobacter pylori en la mucosa gástrica: aspectos histológicos y microbiológicos. Med Clin (Barc). 1990;94:561-3.
17. García JA, García JE, García MI, Muñoz JL, Rodríguez M, Cordero M. Características de la infección por Helicobacter pylori (Campylobacter pylori) en nuestro medio. Med Clin (Barc). 1990;95:648-52.
18. Mearin F, Morera M, Cucala M. Symptoms in functional dyspepsia: relationship to gastroduodenal inflammation and dysmotility, duodenogastritic reflux and Helicobacter pylori. Gastroenterology. 1991;100:A122.
19. Pajares JM, Santander C. Prevalence of Helicobacter pylori infection-associated histologic chronic gastritis in the Spanish population. J Gastroenterol. 1996;31 Suppl 9:1-5.
20. Caballero Plasencia AM, Sofos Kontoyannis S, Valenzuela Barranco M, Martin Ruiz JL, Casado Caballero FJ, Guilarte López-Manas J. Epidemiology of dyspepsia in a random mediterranean population. Prevalence of Helicobacter pylori infection. Rev Esp Enferm Dig. 2000;92:781-92.
21. Montoro MA, Santolaria S. Quality of life in patients with functional dyspepsia. Gastroenterol Hepatol. 2004;27 Suppl 3:15-23.
22. Kuykendall DH, Rabeneck L, Campbell CJM, Wray NP. Dyspepsia: how should we measure it? J Clin Epidemiol. 1998;51:99-106.
23. Ruiz M, Villasante F, León F, González-Lara V, González C, Crespo M, et al. Cuestionario sobre calidad de vida asociada a dispepsia. Adaptación española y validación del cuestionario Dyspepsia Related Health Scale. Med Clin (Barc). 2001;117:567-73.
24. Dixon MF, Genta RM, Yardley J, et al. Clasification and grading of gastritis: The up-dated Sydney System: International Workshop on the Histology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-81.
25. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology. 1993;105:1378-86.
26. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology. 2004;127:1239-55.
27. Rodrigo Sáez L, Riestra Menéndez S, Fernández Rodríguez E, Fernández Velázquez MR, García Alonso S, Lauret Brana ME. Epidemiological study of the prevalence of Helicobacter pylori infection in the general population in Asturias, Spain. Rev Esp Enferm Dig. 1997;89:511-22.
28. Martin de Argila C, Boixeda D, Canton R, Mir N, De Rafael L, Gisbert J, et al. Helicobacter pylori infection in a healthy population in Spain. Eur J Gastroenterol Hepatol. 1996;8: 1165-8.
29. Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci. 1995;40:584-9.
30. Boixeda D, Gisbert JP, Martín de Argila C, Cantón R, Bermejo R, García A. ¿Existe alguna relación entre la sintomatología digestiva y la infección por Helicobacter pylori? Rev Esp Enf Digest. 1995;87:8-14.
31. Heikkinen M, Vornanen M, Hollmen S, Farkkila M. Prognostic significance of antrum-predominant gastritis in functional dyspepsia. Scand J Gastroenterol. 2004;39:227-31.
32. Gisbert JP, Blanco M, Cruzado AI, Pajares JM. Helicobacter pylori infection, gastric metaplasia in the duodenum and the relationship with ulcer recurrence. Eur J Gastroenterol Hepatol. 2000;12:1295-8.
33. Aragonés N, Pollán M, López-Abente G, Ruiz M, Vergara A, Moreno C, et al. Time trend and age-period-cohort effects on gastric cancer incidence in Zaragoza and Navarre, Spain. J Epidemiol Community Health. 1997;51:412-7.